SEC Form 4 · accession 0001192482-15-000445
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donna Nichols
Officer — CAO/Controller
Period of report
Dec 16, 2015
Accepted (ET)
Dec 18, 2015 · 2:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $8.41 | Dec 16, 2015 | A | 16,000 | A | — | Dec 16, 2025 | Common Stock | 16,000 | 16,000 | D |
Explanation of responses
- F1The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.